Because autophagy is one of the adaptive mechanisms of resistance to inhibition of the PI3K–AKT pathway [8], we studied whether autophagy inhibition could augment the anti-tumor efficacy of PI3K inhibitor in PIK3CA-mutant or wild-type cancer cell lines. The gene discussed is AKT1; the disease is neoplasm.